Authors

Andrew Radtke, MD
Recent : Going “retro”: A perspective on robotic retroperitoneal renal surgery
Caroline Seymour
Recent : Pembrolizumab plus cabozantinib highly active in metastatic kidney cancer
Janelle Hart
Recent : Trial of vibegron yields favorable results for patients with OAB
Brian Helfand, MD, PhD
Recent : Follow-Up After Negative Bone/CT in Prostate Cancer With Molecular Recurrence 
Kathleen M. Olson, MD
Recent : Urologic implications of Lynch syndrome
Rachelle Manookian, MS, CGC
Recent : Genetic counselor discusses her role in patient care

Rachelle Manookian, MS, LCGC, is a board-certified genetic counselor specializing in cancer genetics. She has an MS in genetic counseling from the Icahn School of Medicine at Mount Sinai, and a BS in biological sciences with a focus in neurobiology from University of California Irvine, as well as minors in Spanish literature and cognitive psychology.

Mark D. Tyson, MD, MPH
Recent : Urologic implications of Lynch syndrome
Matthew Fowler
Recent : 2-year data for abiraterone regimen show sustained OS benefit in nonmetastatic prostate cancer
Courtney Marabella
Recent : Update offers clues to optimal olaparib use in prostate cancer
Darlene Dobkowski, MA
Recent : Genomic analysis offers clinical insight into VHL-positive vs -negative ccRCC tumors